249 related articles for article (PubMed ID: 34091030)
1. Progression along data-driven disease timelines is predictive of Alzheimer's disease in a population-based cohort.
Venkatraghavan V; Vinke EJ; Bron EE; Niessen WJ; Ikram MA; Klein S; Vernooij MW;
Neuroimage; 2021 Sep; 238():118233. PubMed ID: 34091030
[TBL] [Abstract][Full Text] [Related]
2. Analyzing the effect of APOE on Alzheimer's disease progression using an event-based model for stratified populations.
Venkatraghavan V; Klein S; Fani L; Ham LS; Vrooman H; Ikram MK; Niessen WJ; Bron EE;
Neuroimage; 2021 Feb; 227():117646. PubMed ID: 33338617
[TBL] [Abstract][Full Text] [Related]
3. A parameter-efficient deep learning approach to predict conversion from mild cognitive impairment to Alzheimer's disease.
Spasov S; Passamonti L; Duggento A; Liò P; Toschi N;
Neuroimage; 2019 Apr; 189():276-287. PubMed ID: 30654174
[TBL] [Abstract][Full Text] [Related]
4. The Effect of the APOE Genotype on Individual BrainAGE in Normal Aging, Mild Cognitive Impairment, and Alzheimer's Disease.
Löwe LC; Gaser C; Franke K;
PLoS One; 2016; 11(7):e0157514. PubMed ID: 27410431
[TBL] [Abstract][Full Text] [Related]
5. Multi-study validation of data-driven disease progression models to characterize evolution of biomarkers in Alzheimer's disease.
Archetti D; Ingala S; Venkatraghavan V; Wottschel V; Young AL; Bellio M; Bron EE; Klein S; Barkhof F; Alexander DC; Oxtoby NP; Frisoni GB; Redolfi A; ;
Neuroimage Clin; 2019; 24():101954. PubMed ID: 31362149
[TBL] [Abstract][Full Text] [Related]
6. APOE-by-sex interactions on brain structure and metabolism in healthy elderly controls.
Sampedro F; Vilaplana E; de Leon MJ; Alcolea D; Pegueroles J; Montal V; Carmona-Iragui M; Sala I; Sánchez-Saudinos MB; Antón-Aguirre S; Morenas-Rodríguez E; Camacho V; Falcón C; Pavía J; Ros D; Clarimón J; Blesa R; Lleó A; Fortea J;
Oncotarget; 2015 Sep; 6(29):26663-74. PubMed ID: 26397226
[TBL] [Abstract][Full Text] [Related]
7. Longitudinal structural cerebral changes related to core CSF biomarkers in preclinical Alzheimer's disease: A study of two independent datasets.
Falcon C; Tucholka A; Monté-Rubio GC; Cacciaglia R; Operto G; Rami L; Gispert JD; Molinuevo JL;
Neuroimage Clin; 2018; 19():190-201. PubMed ID: 30023169
[TBL] [Abstract][Full Text] [Related]
8. Large intracranial volume accelerates conversion to dementia in males and APOE4 non-carriers with mild cognitive impairment.
An H; Son SJ; Cho S; Cho EY; Choi B; Kim SY;
Int Psychogeriatr; 2016 May; 28(5):769-78. PubMed ID: 26674540
[TBL] [Abstract][Full Text] [Related]
9. ApoE4 effects on automated diagnostic classifiers for mild cognitive impairment and Alzheimer's disease.
Apostolova LG; Hwang KS; Kohannim O; Avila D; Elashoff D; Jack CR; Shaw L; Trojanowski JQ; Weiner MW; Thompson PM;
Neuroimage Clin; 2014; 4():461-72. PubMed ID: 24634832
[TBL] [Abstract][Full Text] [Related]
10. Alzheimer's polygenic risk scores, APOE, Alzheimer's disease risk, and dementia-related blood biomarker levels in a population-based cohort study followed over 17 years.
Stocker H; Trares K; Beyer L; Perna L; Rujescu D; Holleczek B; Beyreuther K; Gerwert K; Schöttker B; Brenner H
Alzheimers Res Ther; 2023 Jul; 15(1):129. PubMed ID: 37516890
[TBL] [Abstract][Full Text] [Related]
11. Five-Year Longitudinal Brain Volume Change in Healthy Elders at Genetic Risk for Alzheimer's Disease.
Reiter K; Nielson KA; Durgerian S; Woodard JL; Smith JC; Seidenberg M; Kelly DA; Rao SM
J Alzheimers Dis; 2017; 55(4):1363-1377. PubMed ID: 27834774
[TBL] [Abstract][Full Text] [Related]
12. Tensor-based morphometry as a neuroimaging biomarker for Alzheimer's disease: an MRI study of 676 AD, MCI, and normal subjects.
Hua X; Leow AD; Parikshak N; Lee S; Chiang MC; Toga AW; Jack CR; Weiner MW; Thompson PM;
Neuroimage; 2008 Nov; 43(3):458-69. PubMed ID: 18691658
[TBL] [Abstract][Full Text] [Related]
13. Neuroimaging biomarkers for Alzheimer's disease in asymptomatic APOE4 carriers.
Chételat G; Fouquet M
Rev Neurol (Paris); 2013 Oct; 169(10):729-36. PubMed ID: 24016463
[TBL] [Abstract][Full Text] [Related]
14. Age and the association between apolipoprotein E genotype and Alzheimer disease: A cerebrospinal fluid biomarker-based case-control study.
Saddiki H; Fayosse A; Cognat E; Sabia S; Engelborghs S; Wallon D; Alexopoulos P; Blennow K; Zetterberg H; Parnetti L; Zerr I; Hermann P; Gabelle A; Boada M; Orellana A; de Rojas I; Lilamand M; Bjerke M; Van Broeckhoven C; Farotti L; Salvadori N; Diehl-Schmid J; Grimmer T; Hourregue C; Dugravot A; Nicolas G; Laplanche JL; Lehmann S; Bouaziz-Amar E; ; Hugon J; Tzourio C; Singh-Manoux A; Paquet C; Dumurgier J
PLoS Med; 2020 Aug; 17(8):e1003289. PubMed ID: 32817639
[TBL] [Abstract][Full Text] [Related]
15. Classifying Alzheimer's disease with brain imaging and genetic data using a neural network framework.
Ning K; Chen B; Sun F; Hobel Z; Zhao L; Matloff W; ; Toga AW
Neurobiol Aging; 2018 Aug; 68():151-158. PubMed ID: 29784544
[TBL] [Abstract][Full Text] [Related]
16. HMGCR is a genetic modifier for risk, age of onset and MCI conversion to Alzheimer's disease in a three cohorts study.
Leduc V; De Beaumont L; Théroux L; Dea D; Aisen P; Petersen RC; ; Dufour R; Poirier J
Mol Psychiatry; 2015 Jul; 20(7):867-73. PubMed ID: 25023145
[TBL] [Abstract][Full Text] [Related]
17. Cohort-Specific Optimization of Models Predicting Preclinical Alzheimer's Disease, to Enhance Screening Performance in the Middle of Preclinical Alzheimer's Disease Clinical Studies.
Sato K; Mano T; Ihara R; Suzuki K; Niimi Y; Toda T; Iwatsubo T; Iwata A
J Prev Alzheimers Dis; 2021; 8(4):503-512. PubMed ID: 34585226
[TBL] [Abstract][Full Text] [Related]
18. APOE4 Status is Related to Differences in Memory-Related Brain Function in Asymptomatic Older Adults with Family History of Alzheimer's Disease: Baseline Analysis of the PREVENT-AD Task Functional MRI Dataset.
Rabipour S; Rajagopal S; Yu E; Pasvanis S; Lafaille-Magnan ME; Breitner J; ; Rajah MN
J Alzheimers Dis; 2020; 76(1):97-119. PubMed ID: 32474466
[TBL] [Abstract][Full Text] [Related]
19. Atypical Localization and Dissociation between Glucose Uptake and Amyloid Deposition in Cognitively Normal APOE*E4 Homozygotic Elders Compared with Patients with Late-Onset Alzheimer's Disease.
Pardo JV; Lee JT;
eNeuro; 2018; 5(1):. PubMed ID: 29497704
[TBL] [Abstract][Full Text] [Related]
20. A blood-based screening tool for Alzheimer's disease that spans serum and plasma: findings from TARC and ADNI.
O'Bryant SE; Xiao G; Barber R; Huebinger R; Wilhelmsen K; Edwards M; Graff-Radford N; Doody R; Diaz-Arrastia R; ;
PLoS One; 2011; 6(12):e28092. PubMed ID: 22163278
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
